Align Technology | Des Atouts



Assets Changement Date
3M USD 39.87B 1.01B 2024-12
Align Technology USD 6.21B 151.37M 2024-12
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Cardinal Health USD 47B 3.94B 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Cooper Companies USD 12.22B 93M 2025-01
CVS Health USD 253.22B 788M 2024-12
Danaher USD 77.54B 3.07B 2024-12
Dentsply International USD 5.75B 873M 2024-12
Dexcom USD 6.48B 130.7M 2024-12
Henry Schein USD 10.22B 387M 2024-12
Idexx Laboratories USD 3.29B 57.32M 2024-12
Insulet USD 3.09B 62.3M 2024-12
Integra LifeSciences USD 4.04B 28.38M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Masimo USD 2.63B 462.1M 2024-12
McKesson USD 71.08B 1.35B 2024-12
Mettler Toledo International USD 3.24B 79.83M 2024-12
Patterson Companies USD 2.83B 13.02M 2025-01
Revvity USD 12.39B 377.26M 2024-12
Solventum Corp 14.46B 288M 2024-12
Stryker USD 42.97B 862M 2024-12
Teleflex USD 7.1B 388.38M 2024-12
Thermo Fisher Scientific USD 97.32B 3.04B 2024-12
Veeva Systems USD 7.34B 886.9M 2025-01
Walgreens Boots Alliance USD 70.22B 8.32B 2025-02
Waters USD 4.55B 42.18M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12
Zoetis USD 14.24B 120M 2024-12



Align Technology Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.